Cell Death Dis:FGF21可增加移植皮瓣的存活预后

2019-11-25 QQY MedSci原创

随机皮瓣,由于其易得且无轴向血管限制的特点而常被用于外科手术——组织重建。而缺血性坏死则是一种常见的并发症,尤其容易出现在皮瓣的远端。既往研究表明,FGF21可以促进血管生成并可预防缺血性心血管疾病,但FGF21对皮瓣存活的影响尚不明确。在本研究中,研究人员使用大鼠随机皮瓣模型,发现FGF21在成功存活的皮瓣中的表达量显著增加,提示FGF21可能对皮瓣的存活起关键作用。随后研究人员通过实验进一步来

随机皮瓣,由于其易得且无轴向血管限制的特点而常被用于外科手术——组织重建。而缺血性坏死则是一种常见的并发症,尤其容易出现在皮瓣的远端。既往研究表明,FGF21可以促进血管生成并可预防缺血性心血管疾病,但FGF21对皮瓣存活的影响尚不明确。

在本研究中,研究人员使用大鼠随机皮瓣模型,发现FGF21在成功存活的皮瓣中的表达量显著增加,提示FGF21可能对皮瓣的存活起关键作用。随后研究人员通过实验进一步来阐明FGF21在该模型中的作用,发现FGF21是通过增强血管生成、抑制细胞凋亡和减少氧化应激反应从而直接增加皮瓣的存活面积、血流强度和平均血管密度。

此外,研究人员还发现予以FGF21能够增强自噬,而FGF21所起的有益作用能够被自噬抑制剂3-甲基腺嘌呤(3MA)所逆转,提示在皮瓣存活过程中,自噬在FGF21对皮瓣存活的治疗性益处中起着核心作用。更深入的机制研究表明FGF21诱导自噬增强是由TFEB的去磷酸化和核易位所介导的;而这种作用是通过AMPK-FoxO3a-SPK2-CARM1和AMPK-mTOR两种信号通路的激活所完成的。

综上所述,该文章表明FGF21是细胞自噬的有效调节剂,能够显著提高随机皮瓣的生存能力,因此也为临床应用提供一个新的希望。

原始出处:

Zhou et al. FGF21 augments autophagy in random-pattern skin flaps via AMPK signaling pathways and improves tissue survival.Cell Death and Disease ( 2019) 10:872. https://doi.org/10.1038/s41419-019-2105-0

本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2013106, encodeId=ace920131060d, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Tue Jun 16 07:03:00 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961786, encodeId=6a1b1961e8698, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sun Jan 26 06:03:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871497, encodeId=b06718e1497fb, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Dec 25 11:03:00 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425636, encodeId=0c611425636f5, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469333, encodeId=caa014693338b, content=<a href='/topic/show?id=70f0e39358' target=_blank style='color:#2F92EE;'>#FGF21#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7393, encryptionId=70f0e39358, topicName=FGF21)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb327012297, createdName=zhty5339, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531490, encodeId=dec0153149022, content=<a href='/topic/show?id=770e5e9457' target=_blank style='color:#2F92EE;'>#Death#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5794, encryptionId=770e5e9457, topicName=Death)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e312278742, createdName=cy0328, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2013106, encodeId=ace920131060d, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Tue Jun 16 07:03:00 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961786, encodeId=6a1b1961e8698, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sun Jan 26 06:03:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871497, encodeId=b06718e1497fb, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Dec 25 11:03:00 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425636, encodeId=0c611425636f5, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469333, encodeId=caa014693338b, content=<a href='/topic/show?id=70f0e39358' target=_blank style='color:#2F92EE;'>#FGF21#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7393, encryptionId=70f0e39358, topicName=FGF21)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb327012297, createdName=zhty5339, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531490, encodeId=dec0153149022, content=<a href='/topic/show?id=770e5e9457' target=_blank style='color:#2F92EE;'>#Death#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5794, encryptionId=770e5e9457, topicName=Death)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e312278742, createdName=cy0328, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=)]
    2020-01-26 维他命
  3. [GetPortalCommentsPageByObjectIdResponse(id=2013106, encodeId=ace920131060d, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Tue Jun 16 07:03:00 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961786, encodeId=6a1b1961e8698, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sun Jan 26 06:03:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871497, encodeId=b06718e1497fb, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Dec 25 11:03:00 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425636, encodeId=0c611425636f5, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469333, encodeId=caa014693338b, content=<a href='/topic/show?id=70f0e39358' target=_blank style='color:#2F92EE;'>#FGF21#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7393, encryptionId=70f0e39358, topicName=FGF21)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb327012297, createdName=zhty5339, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531490, encodeId=dec0153149022, content=<a href='/topic/show?id=770e5e9457' target=_blank style='color:#2F92EE;'>#Death#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5794, encryptionId=770e5e9457, topicName=Death)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e312278742, createdName=cy0328, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2013106, encodeId=ace920131060d, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Tue Jun 16 07:03:00 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961786, encodeId=6a1b1961e8698, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sun Jan 26 06:03:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871497, encodeId=b06718e1497fb, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Dec 25 11:03:00 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425636, encodeId=0c611425636f5, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469333, encodeId=caa014693338b, content=<a href='/topic/show?id=70f0e39358' target=_blank style='color:#2F92EE;'>#FGF21#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7393, encryptionId=70f0e39358, topicName=FGF21)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb327012297, createdName=zhty5339, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531490, encodeId=dec0153149022, content=<a href='/topic/show?id=770e5e9457' target=_blank style='color:#2F92EE;'>#Death#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5794, encryptionId=770e5e9457, topicName=Death)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e312278742, createdName=cy0328, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=)]
    2019-11-27 sunylz
  5. [GetPortalCommentsPageByObjectIdResponse(id=2013106, encodeId=ace920131060d, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Tue Jun 16 07:03:00 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961786, encodeId=6a1b1961e8698, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sun Jan 26 06:03:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871497, encodeId=b06718e1497fb, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Dec 25 11:03:00 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425636, encodeId=0c611425636f5, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469333, encodeId=caa014693338b, content=<a href='/topic/show?id=70f0e39358' target=_blank style='color:#2F92EE;'>#FGF21#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7393, encryptionId=70f0e39358, topicName=FGF21)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb327012297, createdName=zhty5339, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531490, encodeId=dec0153149022, content=<a href='/topic/show?id=770e5e9457' target=_blank style='color:#2F92EE;'>#Death#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5794, encryptionId=770e5e9457, topicName=Death)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e312278742, createdName=cy0328, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=)]
    2019-11-27 zhty5339
  6. [GetPortalCommentsPageByObjectIdResponse(id=2013106, encodeId=ace920131060d, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Tue Jun 16 07:03:00 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961786, encodeId=6a1b1961e8698, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sun Jan 26 06:03:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871497, encodeId=b06718e1497fb, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Dec 25 11:03:00 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425636, encodeId=0c611425636f5, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469333, encodeId=caa014693338b, content=<a href='/topic/show?id=70f0e39358' target=_blank style='color:#2F92EE;'>#FGF21#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7393, encryptionId=70f0e39358, topicName=FGF21)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb327012297, createdName=zhty5339, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531490, encodeId=dec0153149022, content=<a href='/topic/show?id=770e5e9457' target=_blank style='color:#2F92EE;'>#Death#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5794, encryptionId=770e5e9457, topicName=Death)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e312278742, createdName=cy0328, createdTime=Wed Nov 27 11:03:00 CST 2019, time=2019-11-27, status=1, ipAttribution=)]
    2019-11-27 cy0328

相关资讯

SCI REP:老年与非老年代谢综合征患者认知衰退相关的因素:FGF21的不同作用!

由此可见,这项研究表明FGF21水平与非老年患者的认知障碍独立相关,但与老年患者无关。FGF21水平在非老年人认知损害中的可能作用应在前瞻性研究中予以确认。

JAHA:循环成纤维细胞生长因子21在2型糖尿病患者冠心病初级预防中的作用!

研究人员首次证明了血清FGF21水平是冠心病发病的一个独立预测因子,在初级预防中其可以作为鉴别2型糖尿病患者冠心病风险升高个体的有用的生物标志物。

CLIN CHEM:非诺贝特治疗后FGF21基线循环浓度增加可预测2型糖尿病血糖进展

近日,国际杂志 《Clinical Chemistry》上在线发表一项关于FIELD研究结果,发现非诺贝特治疗后FGF21基线循环浓度增加可预测2型糖尿病更快的血糖进展。 关于成纤维细胞生长因子21(FGF21)浓度是否与确诊的2型糖尿病患者的血糖升高相关尚无定论。本研究报道了糖尿病患者在非诺贝特干预实验和2型糖尿病事件降低(FIELD)试验的关系。

Metabolism:成纤维细胞生长因子21在心脏代谢紊乱中的作用!

由此可见,FGF21可以显著预测冠状动脉疾病的发病率,代谢综合征的风险,糖尿病和糖尿病患者肾功能的进展。它也可以预测全因和心血管死亡率。

Eur Respir J:成纤维细胞生长因子21预测社区获得性肺炎患者结局

由此可见,较高FGF21水平的中重度CAP患者临床不稳定,住院时间延长和30天全因死亡率增加。

Metabolism:血浆高FGF21水平可预测接受阿托伐他汀治疗患者的主要心血管事件

由此可见,较高的血浆FGF21水平与接受他汀类药物治疗的高风险患者较高的CVD风险有关。更高剂量的阿托伐他汀与FGF21水平的降低有关。FGF21为他汀类药物治疗患者的CVD风险预测提供了增量价值。